A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon aloneGiovanna Fattovich, A. Tagger, I. Zagni et al.|Journal of Viral Hepatitis|2004Cited by 11
Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto NetworksElisabetta Degasperi, S. Fagiuoli, Angiola Spinetti et al.|Digestive and Liver Disease|2019Cited by 1
Efficacy and safety of consensus interferon (CIFN) plus ribavirin (RBV) for naive patients with chronic hepatitis C (CHC): Final report of a pilot studyG. Fattovich, A. Tagger, I. Zagni et al.|Journal of Hepatology|2003Cited by 0
Final report of a consensus interferon (CIFN) plus ribavirin (RBV) study for chronic hepatitis C (CHC)I. Zagni, Giovanna Fattovich, E. Minóla et al.|Unknown|2003Cited by 0
Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern ItalyPaolo Fabris, S. Fagiuoli, Franco Noventa et al.|Digestive and Liver Disease|2020Cited by 0